A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects

PLoS ONE
Q1
Jul 2018
Citations:88
Influential Citations:7
Interventional (Human) Studies
85
S2 IconPDF Icon

Enhanced Details

Methods
Single-centre, parallel-group, double-blind randomized controlled trial in healthy adults (n=37). Randomized to maltodextrin (n=18) or oligofructose (n=19) supplementation while following a 7-day low FODMAP diet. Baseline ages: MD 23.5±2.9; OF 26.5±12.2. Gender distribution: MD 14M/4F; OF 11M/8F. Exclusions included pregnancy, inability to comply with diet, pre-existing GI disorders or IBS, antibiotics or probiotics in past 8 weeks, MRI contraindications.
Intervention
Low FODMAP diet for 7 days with supplementation of either oligofructose or maltodextrin (7 g twice daily).
Results
A 7-day low FODMAP diet reduced breath hydrogen and total microbial load; oligofructose supplementation reversed the hydrogen reduction and increased Bifidobacterium abundance, while maltodextrin did not. Colonic volume increased after the diet in both groups (approximately +90 ml for maltodextrin and +110 ml for oligofructose) with no significant between-group difference. Taxa shifts differed by supplement: maltodextrin reduced Bifidobacterium and increased Bilophila; oligofructose increased Actinobacteria (notably Bifidobacterium) and reduced Lachnospiraceae. Methane levels did not change significantly. Breath hydrogen and total gas production correlated with colonic volume and microbial diversity. Conclusion: A low FODMAP diet reduces total bacterial count and gas production with little effect on colonic volume. In healthy adults, changes in microbiota and gas production occur with minimal distension changes; symptom relief on low FODMAPs in IBS may be driven more by reduced microbial fermentation than by reduced colonic distension. To maintain beneficial bacteria during a low FODMAP diet, prebiotic supplementation (e.g., oligofructose) may offset reductions in Bifidobacterium.
Limitations
Small sample size (n=37 completed); short duration (7 days); exploratory microbiota/metabolomics analyses; healthy population limits generalizability to IBS or clinical settings; single-centre design; lack of measured clinical outcomes.

Abstract

Background & aims Ingestion of poorly digested, fermentable carbohydrates (fermentable oligo-, di-, mono-saccharides and polyols; FODMAPs) have been implicated in exacerbating intestinal symptoms and the reduction of intake with symptom alleviation. ...